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Macrophages (Ms) and DCs are central com-
ponents of the mononuclear phagocyte system 
and arise from myeloid progenitor cells resid-
ing in the bone marrow (Varol et al., 2009c; 
Geissmann et al., 2010; Liu and Nussenzweig, 
2010). Recently, a great deal of progress has 
been made concerning the lineage relationships 
between these progenitors and the circulating 
precursors they continuously generate. Fur-
thermore, the regulation of DC turnover within 
secondary lymphoid organs has been substan-
tially clarified by the identification of blood-
borne pre-DCs as common precursors to all 
classical DC subsets (Liu et al., 2009). However, 
Ms and DCs are also abundant throughout 
all nonlymphoid tissues, and the control of their 
population dynamics has remained poorly under-
stood. At the cellular level, these peripheral M 
and DC pools are thought to be maintained 
by the continual recruitment of blood-borne 
precursors  and  the  in  situ  proliferation  of 
more mature cells (van Furth, 1970; Liu and 
Nussenzweig, 2010). However, detailed mecha-
nistic experiments have been hampered by the 
slow turnover of the cells at steady-state and the 
multiple and diverse effects of the key cytokines 
and chemokines that control their production 
and distribution.
The  difficulty  in  studying  M  and  DC 
population  dynamics  in  nonlymphoid  tissues   
is exemplified by work on the prototypical   
M growth factor colony-stimulating factor 1 
(CSF-1 or M-CSF; Pixley and Stanley, 2004). 
CSF-1 is produced by a variety of stromal and 
epithelial  cell  types  and  signals  through  the 
CSF-1R  (CD115)  tyrosine  kinase  receptor 
(encoded by the Csf1r/c-fms proto-oncogene) 
expressed by cells of the mononuclear phago-
cyte lineage (Sasmono et al., 2003). Although an 
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Tissue macrophages (Ms) and dendritic cells (DCs) play essential roles in tissue homeo­
stasis and immunity. How these cells are maintained at their characteristic densities in differ­
ent tissues has remained unclear. Aided by a novel flow cytometric technique for assessing  
relative rates of blood­borne precursor recruitment, we examined M and DC population 
dynamics in the pregnant mouse uterus, where rapid tissue growth facilitated a dissection 
of underlying regulatory mechanisms. We demonstrate how M dynamics, and thus M 
tissue densities, are locally controlled by CSF­1, a pleiotropic growth factor whose in situ 
level of activity varied widely between uterine tissue layers. CSF­1 acted in part by induc­
ing M proliferation and in part by stimulating the extravasation of Ly6Chi monocytes 
(Mos) that served as M precursors. Mo recruitment was dependent on the production of 
CCR2 chemokine receptor ligands by uterine Ms in response to CSF­1. Unexpectedly, a 
parallel CSF­1–regulated, but CCR2­independent pathway influenced uterine DC tissue 
densities by controlling local pre­DC extravasation rates. Together, these data provide 
cellular and molecular insight into the regulation of M tissue densities under noninflam­
matory conditions and reveal a central role for CSF­1 in the coordination of M and  
DC homeostasis.
© 2011 Tagliani et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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recruitment, and survival) have remained unclear. For reasons 
that are also poorly understood, murine pregnancy is associ-
ated with dramatic and tissue layer–specific shifts in uterine 
M densities (Pollard et al., 1991; Stewart and Mitchell, 1991; 
Brandon, 1995). M tissue densities decline dramatically in 
the decidua, i.e., the specialized and rapidly growing endome-
trial stromal tissue that directly encases the conceptus but are 
maintained in the growing segments of myometrial smooth 
muscle that form the outer portion of each implantation site. 
Recently, we noted a similar behavior with respect to uterine 
DCs, which suggested that Ms and DCs homeostatically 
expand in the myometrium but lose density in the decidua 
through a linked mechanism (Collins et al., 2009). More gen-
erally, these observations suggested that the pregnant uterus 
would provide a robust, yet physiological model system for 
studying M and DC population dynamics. To facilitate our 
analysis, we developed a novel flow cytometric technique that 
allowed us to directly assess relative rates of Mo and pre-DC 
extravasation into peripheral tissues.
We show that increased CSF-1 activity within the grow-
ing myometrium of pregnant mice drives the homeostatic 
expansion of Ms within this tissue layer. CSF-1 not only   
directly  stimulated  the  in  situ  proliferation  of  myometrial 
Ms but also induced M precursor recruitment from the 
blood. These precursors consisted of Ly6Chi Mos, a Mo subset 
which typically gives rise to Ms at sites of inflammation   
after their recruitment by the set of inflammatory chemokine 
ligands  that  engage  the  CCR2  chemokine  receptor  (e.g., 
CCL2/MCP-1; Varol et al., 2009c). Indeed, CCR2 ligands 
also  mediated  Ly6Chi  Mo  extravasation  into  the  growing 
myometrium, but their localized expression was not caused 
by an underlying inflammatory process but rather by the 
select action of CSF-1 itself on myometrial Ms. Critically,   
a  parallel  CSF-1–driven,  but  CCR2  ligand–independent 
pathway induced pre-DC extravasation into the myometrium 
to promote the expansion of CD11bhi DCs. In addition to 
explaining the spatial distribution of Ms and DCs in the 
pregnant mouse uterus, these data give fundamental insight 
into how CSF-1 controls M tissue densities under non-
inflammatory  conditions  and  reveal  an  intimate,  CSF-1– 
mediated link between tissue M and DC homeostasis.
RESULTS
Pregnancy entails tissue layer–specific shifts in uterine M 
and DC densities
The  mouse  uterus  contains  two  abundant  populations  of 
Ms, defined by F4/80+ MHCIIhi and F4/80+ MHCIIlo sur-
face phenotypes, as well as many F4/80 MHCIIhi CD11chi 
DCs  with  LN-homing  capacity  that  divide  into  CD11blo 
(CD103+) and CD11bhi (CD103) subsets (Fig. 1 A; Collins 
et al., 2009). As shown by F4/80 and CD11c immunohisto-
chemistry (Fig. 1 B), these cells were evenly distributed   
between  the  myometrium  and  endometrium  at  the  time   
of implantation on embryonic day (E) 4.5 but lost tissue den-
sity selectively within the decidua upon growth of the im-
plantation site, in accord with prior data (Pollard et al., 1991; 
overall  requirement  for  CSF-1–CSF-1R  interactions  in   
generating tissue Ms is clear from the paucity of these 
cells in CSF-1–deficient (Csf1op/op) and CSF-1R–deficient 
(Csf1r/) mice (Wiktor-Jedrzejczak et al., 1990; Dai et al., 
2002), the specific contributions of CSF-1–regulated path-
ways  to  the  control  of  M  homeostasis  remain  poorly   
defined. One site of action is thought to be the bone marrow, 
where CSF-1 facilitates the production of blood monocytes 
(Mos) that serve as M precursors (Pixley and Stanley, 2004). 
However, systemic CSF-1 injection into Csf1op/op mice fails to 
normalize M densities in all tissues (Cecchini et al., 1994), 
and several experimental models have shown that tissue- 
restricted  CSF-1  overexpression  increases  local  M  tissue 
densities (Moore et al., 1996; Naito et al., 1996; Lin et al., 
2001). Together, these results suggest that CSF-1 can act in-
structively within peripheral tissues themselves. Based upon 
in vitro data but limited evidence in vivo, such tissue-level   
effects might include increased M proliferation or survival 
(Tushinski et al., 1982; Le Meur et al., 2002b; Jose et al., 2003). 
It has also been suggested that local CSF-1 expression might 
increase Mo recruitment from the blood (Lenda et al., 2003), 
an idea which is superficially consistent with the ability of 
CSF-1 to induce Mo and M chemotaxis (Wang et al., 1988; 
Jones, 2000). However, this possibility lacks direct evidence 
and conflicts with the notion that Mo extravasation is pre-
dominantly a chemokine-driven process.
The role of CSF-1 in DC homeostasis has also remained 
unclear. Consistent with their greatly reduced abundance in 
Csf1r/ mice, epidermal Langerhans cells and CX3CR1hi 
DCs in the gut lamina propria are both thought to be Mo 
derived (Dai et al., 2002; Ginhoux et al., 2006; Bogunovic   
et al., 2009; Varol et al., 2009b). In contrast, pre-DCs likely 
give rise to the CD103+ CD11blo and CD103 CD11bhi DC 
subsets common to many tissues (Ginhoux et al., 2009). 
Although no absolute deficits in these two latter subsets have 
been noted in the absence of CSF-1 signaling, both CD11bhi 
DCs and pre-DCs express CD115, and Csfr1/ mice show a   
relative loss of peripheral CD11bhi CD103 DCs as com-
pared with CD11blo CD103+ DCs (Ginhoux et al., 2009; 
Schmid et al., 2010). It is unclear whether this phenotype   
is the result of the two subsets having a differential depen-
dence on CSF-1 for in situ proliferation and/or survival or 
the result of a differential dependence on pre-DC or Mo re-
cruitment from the blood. The pathways that drive pre-DC 
extravasation into peripheral tissues are also currently unclear, 
and  whether  these  pathways  might  be  CSF-1  regulated   
is unknown.
A large body of literature has documented the impor-
tance  of  CSF-1  in  controlling  M  tissue  densities  in  the 
mouse uterus (Cohen et al., 1999). Regulation of uterine 
CSF-1 expression by sex hormones is thought to explain the 
estrous cycle–related changes in uterine M densities, and 
intraluminal CSF-1 injection into the uteri of ovariectomized 
mice  increases  uterine  M  densities  (Pollard  et  al.,  1987; 
Wood et al., 1992). As with other organ systems, however, the 
cellular parameters locally regulated by CSF-1 (i.e., proliferation, JEM Vol. 208, No. 9 
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proportion of intra-
vascular versus extra-
vascular leukocytes   
in a tissue. Analo-
gous to prior work 
(Galkina et al., 2005; 
Pereira et al., 2009), 
this  technique  in-
volved injecting mice i.v. ≤5 min before sacrifice with a low 
dose (1 µg/mouse) of fluorochrome-conjugated antibodies 
(Abs) specific for the pan-leukocyte marker CD45. As ex-
pected, this led to 100% of blood leukocytes becoming fluo-
rochrome+ (Fig. 2 C, left). In contrast, cell suspensions prepared 
from E8.5 uterine tissues and gated on total CD45+ cells 
showed distinct fluorochrome+ versus fluorochrome sub-
populations, which we interpreted as being intravascular and 
extravascular leukocytes, respectively (Fig. 2 C, middle and 
right). The validity of this interpretation was confirmed by 
immunofluorescence staining of implantation sites from E8.5 
pregnant mice i.v. injected with biotin-conjugated anti-CD45 
Abs,  which  revealed  the  biotin+  cells  exclusively  within 
CD31+  blood  vessels  (Fig.  2,  D  and  E).  Multicolor  flow   
cytometry furthermore allowed us to determine the blood/
tissue partitioning of any leukocyte subtype of interest in a 
given cell suspension. Thus, in the aforementioned experi-
ment (Fig. 2 C), we used CX3CR1GFP reporter mice to iden-
tify myeloid cell types such as Mos and Ms by virtue of   
their GFP fluorescence (Geissmann et al., 2003). Strikingly,   
a much larger proportion of GFP+ cells were in the intravas-
cular  compartment  in  the  decidua  as  compared  with  the 
myometrium, which is again consistent with a defect in   
precursor extravasation.
Stewart and Mitchell, 1991; Brandon, 1995; Collins et al., 
2009). A similar result was obtained via a flow cytometric 
analysis of cell suspensions prepared from dissected uterine 
tissue layers, which allowed us to more accurately identify cell 
subsets and quantitate their tissue densities (Fig. 1 C). Strik-
ingly, M and DC densities in the growing segments of 
myometrium overlying each implantation site at midgestation   
(i.e., E9.5–10.5) were roughly similar to those seen in the   
total uterus on E4.5, indicating the rapid homeostatic expan-
sion of the cells within this tissue layer. Importantly, analysis 
by Annexin V/7-AAD staining argued against a process of   
selective DC or M apoptosis in the decidua (unpublished 
data), and we also previously showed that the decrease in de-
cidual DC density was not caused by DC emigration (Collins 
et al., 2009).
Myometrial growth is associated with uniquely high 
extravasation rates of Ly6Chi Mos and pre­DCs
To understand why M and DC population dynamics dif-
fered so dramatically between the myometrium and decidua, 
we first made note of the prior observation that the decidual 
vascular zone contains many Mo-like cells adherent to the 
luminal side of vessel endothelium, even after vascular perfu-
sion, but a relative paucity of leukocytes from the underlying 
parenchyma (Welsh and Enders, 1985; Kruse et al., 1999). 
Because many of the vascular adherent cells also express 
appreciable levels of the DC marker CD11c (Fig. 2, A and B; 
Behrends et al., 2008), it raised the possibility that Ms and 
DCs failed to expand in the decidua because this tissue layer 
was  not  able  to  induce  the  extravasation  of  key  cellular 
precursors. To explore this possibility in more detail, we de-
veloped a technique for quantitating, via flow cytometry, the 
Figure 1.  M and DC tissue densities in 
the pregnant uterus. (A) Flow cytometric 
identification of cell populations in uteri of 
virgin mice. Forward versus side scatter and 
7-AAD CD45+ Ly6Cneg-lo gating (not depicted) 
was used to identify all viable leukocytes aside 
from Ly6Chi Mos and eosinophils. (B) Anti-
F4/80 (green) or anti-CD11c (red) immuno-
staining of transverse sections of E4.5 uteri 
(unimplanted segments) and an E9.5 implan-
tation site. Dashed lines demarcate the unde-
cidualized endometrium (endo) from the 
myometrium (myo) on E4.5. The asterisk indi-
cates where part of the antimesometrial de-
cidua (amd) has detached from the slide. The 
arrowheads indicate nonspecific staining of 
the yolk sac. DAPI was used as a counterstain. 
The scale bar applies to all images. Data are 
representative of at least three independent 
experiments. e, embryo; md, mesometrial 
decidua; p, placenta; vz, decidual vascular 
zone. (C) Flow cytometric assessment of  
M and DC tissue densities in the pregnant 
uterus. Cell suspensions prepared from im-
plantation sites at E9.5/10.5 (E9/10), after 
physical separation of the myometrium from 
the decidua (dec) or from the total uterus on 
E4.5. This latter tissue contains equal amounts 
of endometrium and myometrium (Collins  
et al., 2009). n = 4–8 mice per group from 
four independent experiments. Error bars 
indicate SEM.1904 CSF-1 links M and DC population dynamics | Tagliani et al.
different tissues and tissue layers. Strikingly, 24 h after BrdU 
injection,  27–40%  of  Ly6Chi  Mos  and  pre-DCs  in  the 
growing E8.5 myometrium were both BrdU labeled as well 
as located in the extravascular compartment (i.e., were nega-
tive for i.v. injected anti-CD45 Abs; Fig. 4 A). These cells were 
ones that had, during the 24 h between BrdU injection and 
sacrifice, completed DNA replication in the bone marrow, 
transited through the blood to the uterus, and then entered 
the tissue parenchyma. In contrast, only 6–9% of Ly6Chi 
Mos and pre-DCs were both BrdU+ and extravascular in the 
decidua. These data thus indicated that the growing myo-
metrium rapidly recruited both Ly6Chi Mos and pre-DCs from 
the circulation, whereas the extravasation rates of both pre-
cursor cell types were much lower in the decidua.
Importantly, the blood/tissue partitionings of the BrdU-
labeled cohorts of Ly6Chi Mos and pre-DCs in the myo-
metrium and decidua closely approximated the partitionings of 
their respective total populations (Fig. 4 B). This implied that 
measurements of blood/tissue partitionings alone could be 
used to estimate relative extravasation rates in different organs. 
Strikingly, Ly6Chi Mos and pre-DCs (when detectable) were 
both largely (>70%) intravascular in the nonpregnant uterus, 
lung, kidney, and heart (Fig. 4 C). In the lung, this high degree 
of intravascular retention indeed reflected the true state of the 
cells under noninflammatory conditions, as intranasal LPS ad-
ministration induced many lung Mos to shift to an extravas-
cular location, where they subsequently differentiated into 
Next, we used mitotic pulse labeling with the thymidine 
analogue BrdU (which has an 0.5-h half-life in vivo; Packard 
et al., 1973) as a means to track cohorts of newly generated 
Ly6Chi Mos and pre-DCs in vivo. Consistent with their   
intrinsic nonmitotic status (Geissmann et al., 2003), Ly6Chi 
Mos in blood and uterine tissues showed no BrdU labeling   
2 h after a single BrdU injection (Fig. 3 A, top; see Fig. S1 for 
our Mo and pre-DC gating strategies). In contrast, 50% of 
these cells, representing a synchronous cohort of recent bone 
marrow  emigrants  derived  from  dividing  promonocytes   
(van Furth and Cohn, 1968), showed labeling 24 h after injec-
tion  (Fig.  3 A,  bottom). These  labeling  kinetics  moreover 
demonstrated that the entire population of uterine Ly6Chi 
Mos had equilibrated with blood Ly6Chi Mos within 24 h. 
Similarly, pre-DCs in the blood and peripheral tissues showed 
minimal labeling (<0.5%) 2 h after BrdU injection (Fig. 3 B, 
top), but a substantial fraction of the cells became labeled   
24 h after injection, including those in the E8.5 myometrium 
and decidua (Fig. 3 B, bottom). Interestingly, 25% of pre-
DCs in the bone marrow became labeled with BrdU 2 h after 
injection (Fig. 3, B and C), and maximal labeling of the cells 
in peripheral blood (50%) was apparent after 12 h (Fig. 3 C), 
which is consistent with their rapid turnover.
Combining  the  kinetic  dimension  provided  by  BrdU 
pulse labeling with our technique for discriminating intra-
vascular from extravascular leukocytes allowed us to assess 
relative rates of Ly6Chi Mo and pre-DC extravasation into 
Figure 2.  Technique for assessing leukocyte blood/
tissue partitioning. (A and B) Leukocyte localization in the 
decidual vascular zone. Tissue sections from E8.5 implanta-
tion sites were stained with anti-CD45 (A) or anti-CD11c (B) 
Abs (red). Vascular sinusoids are the dark areas containing 
scattered red blood cells that are green-tinged as a byprod-
uct of the staining protocol. Some areas of the decidual 
parenchyma are indicated with asterisks. Data are represen-
tative of at least n = 6 mice from at least six independent 
experiments. (C) Visualization of leukocyte blood/tissue par-
titioning in the blood and the E8.5 myometrium and decidua. 
Pregnant CX3CR1GFP mice were i.v. injected with PE-Cy7–
conjugated anti-CD45 Abs 1 min before sacrifice. Total  
leukocytes in blood and tissue cell preparations were  
subsequently identified with Pacific orange–conjugated anti-
CD45 Abs. Intravascular leukocytes appear as PE-Cy7+, 
whereas extravascular cells appear as PE-Cy7. Data are 
representative of n = 6 mice from four independent experi-
ments. (D and E) Histological validation. Tissue sections from 
E8.5 pregnant mice injected with biotin-conjugated anti-
CD45 Abs 5 min before sacrifice were double stained with 
anti-CD31 Abs (green) and either streptavidin (D; red) or 
anti-CD45 Abs (E; red). The areas shown are at the border 
between the myometrium (myo) and mesometrial decidua 
(dec), where leukocytes are present in the parenchyma of 
both tissue layers. Note that all biotin+ cells are present 
within CD31+ vessels, even within the myometrium (left; 
arrows). Nonvascular CD31+ cells are decidual NK cells. Data 
are representative of n = 2 mice from two independent ex-
periments. DAPI was used as a counterstain.JEM Vol. 208, No. 9 
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cells was still visible in uterine cell suspensions. Strikingly, the 
proportion of these CCR2-deficient cells in the intravascular 
compartment of the myometrium was greatly increased com-
pared with C57BL/6 (B6) controls (Fig. 5 A), whereas the 
largely intravascular partitioning of these cells in the decidua 
remained similar to WT (not depicted). In contrast, pre-DC 
abundance was normal in the blood of Ccr2/ mice (not   
depicted), and the blood/tissue partitioning of these cells in 
the growing myometrium of Ccr2/ mice at midgestation 
was similar to WT (Fig. 5 A). Myometrial pre-DC blood/tissue 
partitioning was also unaltered in pregnant mice deficient in 
CCR1  (unpublished  data),  a  chemokine  receptor  recently 
implicated in pre-DC migration to tumors (Diao et al., 2010). 
Together, these data indicated that Ly6Chi Mo extravasation 
into the growing myometrium was dependent on CCR2, 
whereas  myometrial  pre-DC  extravasation,  although  likely 
chemokine driven, was independent of CCR1 and CCR2.
M and DC differentiation in the pregnant uterus
To determine the fate of Ly6Chi Mos in the pregnant uterus, 
we adoptively transferred Ly6Chi Mos sorted from the bone 
marrow  of  CX3CR1GFP/+  CD45.1  mice  into  congenic 
CD45.2 pregnant recipients.  The cells were MHCII CD11c 
F4/80 at the time of transfer on E4.5 (not depicted) and 
were identified as being GFP+ CD45.1+ 5–6 d later on E9.5–
10.5 (Fig. 6 A, top left). Strikingly, >90% of donor-derived 
cells in the growing myometrium had entered the extravascu-
lar compartment (Fig. 6 A, bottom left, blue cells). A great 
majority  (90%)  of  these  extravasated  cells  displayed  the 
DC-like cells (Fig. 4 D). In contrast, only the spleen and LN 
showed the largely extravascular partitioning of Ly6Chi Mos 
and pre-DCs seen in the growing myometrium (Fig. 4 C), as 
expected from previous results (Liu et al., 2007; Swirski et al., 
2009). Together, these data indicated that the growing myo-
metrium was unique among nonlymphoid tissues in its ability 
to recruit large numbers of Ly6Chi Mos and pre-DCs from 
the circulation under noninflammatory conditions. This in 
turn suggested that high rates of precursor extravasation might 
be critical for maintaining M and DC tissue densities.
CCR2 signaling drives Ly6Chi Mo but not pre­DC 
recruitment to the growing myometrium
Next, we determined the signals that induced Ly6Chi Mo   
and pre-DC extravasation into the growing myometrium. As 
shown in Fig. 5 A, i.v. pertussis toxin (PTX) injection shortly 
before sacrifice on E9.5–10.5 significantly increased the pro-
portion  of  intravascular  Ly6Chi  Mos  and  pre-DCs  in  the 
growing myometrium without changing their abundance in 
the blood (Fig. 5 B). Because PTX inhibits Gi-mediated   
G protein–coupled receptor signaling and thus all chemokine 
receptor signaling, this result suggested that the extravasation 
of both Ly6Chi Mos and pre-DCs was chemokine driven. 
Next, we evaluated the role of CCR2, the chemokine recep-
tor which mediates Ly6Chi Mo recruitment to sites of inflam-
mation. Although Ccr2/ mice show substantially reduced 
numbers of Ly6Chi Mos in the blood and peripheral tissues as 
a result of their defective exit from the bone marrow (Serbina 
and Pamer, 2006; Tsou et al., 2007), a clear population of these 
Figure 3.  Identification of uterine Ly6Chi Mos and pre­DCs recently arriving from the bone marrow. (A and B) BrdU pulse labeling of Mos (A) 
and pre-DCs (B). E7.5 (A) or E9.5–10.5 (B) pregnant mice were BrdU injected 2 or 24 h before sacrifice. Data are representative of n = 3–5 mice per time 
point from two and four independent experiments, respectively (A), and n = 3–7 mice from three and four independent experiments, respectively (B).  
(C) Pre-DC BrdU labeling kinetics in the blood and bone marrow. Mice were BrdU injected at the indicated times before sacrifice. n = 3–7 mice per group 
from five independent experiments. Error bars indicate SEM.1906 CSF-1 links M and DC population dynamics | Tagliani et al.
a much greater propensity to differentiate into Ms upon ex-
travasation (as opposed to DCs; Fig. 6 A, top right); however, 
most of these cells remained undifferentiated and appeared 
retained  within  the  intravascular  compartment  (Fig.  6 A,   
bottom left and middle right, orange cells). Together, these 
F4/80+ MHCIIlo/hi surface phenotype seen with the endoge-
nous population of uterine Ms, whereas only 3% of the 
cells displayed the F4/80 MHCIIhi (and CD11bhi CD11chi; 
not depicted) surface phenotype of CD11bhi DCs (Fig. 6 A, 
top right). Similarly, donor-derived cells in the decidua showed 
Figure 4.  Uniquely high Ly6Chi Mo and pre­DC extravasation rates in the growing myometrium. (A and B) Simultaneous visualization of BrdU 
labeling and blood/tissue partitioning of Ly6Chi Mos and pre-DCs in the E8.5 pregnant uterus. Mice were injected with BrdU 24 h before sacrifice. Repre-
sentative dot plots are shown in A; B shows the mean ± SEM percentage of extravascular (ev) cells calculated for either the BrdU-labeled cohort or total 
population of Ly6Chi Mos or pre-DCs (n = 5–6 mice per group from four and three independent experiments, respectively). Dec, decidua; iv, intravascular; 
Myo, myometrium. (C) Ly6Chi Mo and pre-DC blood/tissue partitioning in lymphoid and nonlymphoid tissues. The myometrium is from an E9.5 pregnant 
mouse; the uterus is from a nonpregnant mouse in diestrus. Pre-DCs in the nonpregnant uterus and heart were very scarce and so are not depicted. Data 
are representative of n = 2–5 mice per group from three and five independent experiments, respectively. scLN, subcutaneous LN. (D) Lung Ly6Chi Mo ex-
travasation and differentiation after the intranasal infusion of PBS or 2 µg LPS. Top panels show the blood/tissue partitioning of Ly6Chi Mos. The CD11c/
MHCII surface phenotype of all Ly6Chi cells is shown in the middle and bottom panels, which are gated on intravascular and extravascular cells, respec-
tively. All plots were generated from the same number of CD45+ cells and thus reveal the relative proportions of the displayed cells in different mice.  
Data are representative of n = 2 mice per group from three independent experiments.JEM Vol. 208, No. 9 
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In contrast, these mice showed no detectable change in myo-
metrial M tissue densities or blood Ly6Chi Mo abundance 
(Fig. 6, B and C). Thus, we conclude that pre-DCs constitute 
the vast majority of precursors for both DC subsets in the 
growing myometrium.
CSF­1–dependent and –independent proliferative responses 
of Ms and DCs in the pregnant uterus
We next measured short-term (2 h) BrdU incorporation rates 
to assess the contribution of in situ proliferation to uterine 
M and DC population dynamics. As shown in Fig. 7 A, 
MHCIIhi and MHCIIlo Ms showed very low levels of BrdU 
incorporation in the nonpregnant uterus (<1%) and rela-
tively low levels in the E4.5 uterus and the E9.5–10.5 de-
cidua (1–5%). In contrast, both M subsets were highly 
proliferative  in  the  growing  myometrium  (10%  BrdU+). 
This phenotype was potentially caused by the elevation in 
uterine CSF-1 expression known to occur during pregnancy 
(Arceci et al., 1989). Indeed, using PCR primers that detect 
all  known  Csf1  messenger  RNA  (mRNA)  isoforms,  we 
found that Csf1 mRNA levels in the growing myometrium 
were  18-,  11-,  and  49-fold  higher  than  the  nonpregnant 
uterus, E4.5 uterus, and decidua, respectively, and 5–30-fold 
higher than all other tissues tested (Fig. 7 B). More impor-
tantly, the injection of anti–CSF-1R blocking Abs 12 h before 
sacrifice dramatically reduced the BrdU labeling of both sub-
sets of Ms in the myometrium without affecting their label-
ing in the decidua (Fig. 7 C). This result indicated that elevated 
CSF-1 activity in the myometrium was directly responsible 
for the in situ proliferation of myometrial Ms.
Next, we examined DC proliferation. BrdU labeling indi-
ces of both CD11blo and CD11bhi DCs were similar in the 
nonpregnant and E4.5 uterus (4–9%). However, by midges-
tation, the labeling of CD11blo DCs increased to 15% and 
12% in the myometrium and decidua, respectively (Fig. 7 D, 
left), whereas the labeling of CD11bhi DCs remained constant 
in the myometrium but declined to 2% in the decidua   
(Fig. 7 D, right). Myometrial CD11bhi DCs were the only DC 
population that showed reduced proliferation after acute 
CSF-1R blockade (Fig. 7 E), whereas CD11blo DCs appeared 
more sensitive to loss of Flt3L (Fig. 7 F). Nonetheless, myo-
metrial CD11blo DCs in pregnant Flt3L/ mice still showed 
substantially  elevated  proliferation  as  compared  with  non-
pregnant controls (Fig. 7, compare F with D; P = 0.001). To-
gether,  these  results  indicated  that  uterine  growth  after 
implantation was associated with an induction of myometrial 
CD11blo DC in situ proliferation, primarily through the ac-
tions of an Flt3L- and CSF-1–independent mitogen, and a 
decrease in decidual CD11bhi DC in situ proliferation.
CSF­1 stimulates Ly6Chi Mo extravasation  
into the myometrium by inducing CCR2 ligand expression  
by myometrial Ms
Along with its inhibitory effect on M proliferation, the in-
jection of anti–CSF-1R Abs 12 h before sacrifice on E9.5–
10.5 unexpectedly increased the proportion of intravascular 
data suggested that Ly6Chi Mos were almost exclusively M 
precursors in the pregnant uterus but robustly differentiated 
only if they could enter the uterine parenchyma.
Given our reliance on the CX3CR1GFP marker to accu-
rately identify donor-derived cells, the aforementioned ex-
periment did not allow us to assess the contribution of Ly6Chi 
Mos to CD11blo DCs, which are CX3CR1 (Jakubzick et al., 
2008). Thus, we also made use of mice deficient in Flt3L, a 
growth factor required for the generation of all DC subsets 
(McKenna et al., 2000). Indeed, the uteri of nonpregnant 
Flt3L/ mice showed >90% reductions in the tissue densi-
ties of both CD11blo and CD11bhi DC subsets as compared 
with WT  controls  (unpublished  data).  Strikingly,  Flt3L/ 
mice at midgestation also showed dramatically reduced densi-
ties of both DC subsets in the growing myometrium (87% 
and 70%, respectively; Fig. 6 B) as well as dramatic reduc-
tions in the abundance of pre-DCs in the blood (Fig. 6 C).   
Figure 5.  PTX sensitivity and CCR2 dependence of precursor re­
cruitment to the myometrium. (A) Blood/tissue partitioning of Ly6Chi 
Mos (top) and pre-DCs (bottom) in the E9.5–10.5 growing myometrium of 
untreated WT mice, WT mice injected i.v. with 0.5 µg PTX 16 h and 15 min 
before sacrifice, or untreated Ccr2/ mice. Data are from two to five 
independent experiments with n = 4–8 mice per group. ev, extravascular; 
iv, intravascular. (B) Effect of PTX treatment on blood Ly6Chi Mo and pre-
DC abundance. E9.5–10.5 pregnant mice were injected with PBS or 0.5 µg 
PTX 16 h and 15 min before sacrifice. n = 2–4 mice per group from three 
independent experiments. Error bars indicate SEM.1908 CSF-1 links M and DC population dynamics | Tagliani et al.
Role of CSF­1 in uterine M maturation  
and phenotypes
We  next  determined  the  effect  of  CSF-1R 
blockade on uterine M densities. In the non-
pregnant uterus, where CSF-1 mRNA levels 
are low (Fig. 7 B), Ms are not proliferating 
(Fig. 7 A), and there is minimal recruitment of 
circulating Ly6Chi Mos (not depicted; Collins 
et  al.,  2009),  treatment  with  anti–CSF-1R   
Abs  for  a  consecutive  3-d  period  led  to   
almost a complete loss of both MHCIIhi and MHCIIlo Ms 
(Fig. 9 A). This result is in accord with recent data (MacDonald 
et al., 2010) and indicated that basal levels of CSF-1R signal-
ing are required for the survival of uterine Ms. In contrast, 
mice treated for 3 d with anti–CSF-1R Abs starting on E6.5–
7.5 still retained relatively large numbers of MHCIIhi Ms in 
the growing myometrium (Fig. 9 A; representative dot plots 
shown  in  Fig.  9  B,  top). This  result  suggested  that  Ab- 
mediated CSF-1R blockade was not complete in the grow-
ing myometrium on E9.5–10.5, where CSF-1 activity is high, 
and that the survival of MHCIIhi Ms might be less depen-
dent on CSF-1R signaling than the survival of MHCIIlo Ms. 
Alternatively, it was possible that CSF-1 had an additional 
function in maintaining newly differentiating Ms as cells 
with a MHCIIlo surface phenotype, as suggested by previous 
in vitro data (Calamai et al., 1982; Willman et al., 1989). In 
this case, the effects of CSF-1R blockade would include the 
conversion of MHCIIlo Ms to MHCIIhi Ms.
Use of Ccr2/ mice allowed us to discriminate between 
these  alternatives.  Nonpregnant  Ccr2/  mice  showed  re-
duced uterine M densities compared with WT (Fig. 9 C). 
Furthermore, the E9.5–10.5 growing myometrium showed 
an 70% reduction in MHCIIhi M densities (Fig. 9 C), even 
though the proliferation rates of both MHCIIhi and MHCIIlo 
myometrial Ms were unaltered in Ccr2/ mice compared 
with WT (not depicted). These results demonstrated that the 
Ly6Chi Mos in the growing myometrium to 40% as com-
pared  with  the  25%  seen  in  isotype  control–treated  mice   
(Fig. 8 A). A similar shift in the blood/tissue partitioning of 
myometrial Ly6Chi Mos was also seen in mice treated for a 
consecutive 3-d period with anti–CSF-1R Abs starting on 
E6.5–7.5 (Fig. 8 A). CSF-1R blockade did not affect the 
abundance of Ly6Chi Mos in the blood (Fig. 8 B) or the 
blood/tissue partitioning of Ly6Chi Mos in the decidua 
(not depicted). Together, these results indicated that CSF-1 
contributed to the elevated rates of Ly6Chi Mo extravasa-
tion within the growing myometrium. However, because 
Mo extravasation was also CCR2 dependent (Fig. 5 A), 
we tested whether CSF-1 was acting indirectly through 
the induction of CCR2 ligands. Indeed, the myometrium 
showed  approximately  three-  to  eightfold  higher  Ccl2, 
Ccl7, and Ccl12 mRNA levels as compared with the de-
cidua, and these levels were dramatically reduced in the 
myometrium but not decidua after short-term CSF-1R 
blockade (Fig. 8 C). Moreover, both flow cytometric and 
immunohistochemical assessments of MCP1-RFP reporter 
mice revealed that almost all CCL2+ cells in the growing 
myometrium were F4/80+ Ms (Fig. 8 D). Together, these 
data indicated that the high rate of Ly6Chi Mo extravasa-
tion into the growing myometrium depended on elevated 
in situ levels of CSF-1 activity that in turn induced the 
expression of CCR2 ligands by myometrial Ms.
Figure 6.  Origin of uterine Ms and DCs. (A) Fate 
of adoptively transferred Ly6Chi Mos. Pregnant CD45.2 
mice on E4.5 were injected with Ly6Chi bone marrow  
Mos from CD45.1 CX3CR1GFP donors. 5 or 6 d later, donor 
cells were identified as being CD45.1+ GFP+ (top left) 
before visualization of their blood/tissue partitioning and 
MHCII expression status (bottom left). The percentage of 
extravascular (ev; blue) or intravascular (iv; orange)  
donor-derived cells in each tissue layer that had become 
Ms or CD11bhi DCs is shown within the two gated pop-
ulations in the top right and middle right plots. The  
bottom right plots show the surface phenotype of the 
endogenous population of extravasated leukocytes (i.e., 
CD45+ cells that are negative for i.v. anti-CD45) in each 
tissue layer. Data are representative of n = 4 mice from 
two independent experiments. (B) M and DC tissue 
densities in the E9.5–10.5 myometrium of Flt3L/ preg-
nant mice. n = 4–8 mice per group from six independent 
experiments. (C) Pre-DC and Ly6Chi Mo abundances in 
the blood of Flt3L/ mice. n = 3–7 mice per group from 
six independent experiments. Error bars indicate SEM.JEM Vol. 208, No. 9 
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angiogenic Ms (Fig. 9 D; Cho et al., 2007). These cells also 
expressed higher levels of genes indicative of the alternatively 
activated (or M2) phenotype associated with tissue remodel-
ing and repair, including Cd163, Stab1 (stabilin-1), and Mrc1 
(mannose receptor). In contrast, the MHCIIhi Ms showed a 
trend toward higher expression levels of Ccl5, Cx3cl1, and 
Ccl17, which encode chemokines expressed more by M1 
Ms  (Movahedi  et  al.,  2010;  unpublished  data). Together, 
these data suggested that the program of CSF-1–induced M 
expansion in the myometrium inherently ensured the pres-
ence of adequate numbers of Ms potentially specialized for 
the demands of tissue growth.
CSF­1 influences DC tissue densities in the growing 
myometrium by regulating the extravasation of their 
precursors from the blood
Unexpectedly, we also found that acute CSF-1R blockade 
affected the blood/tissue partitioning of pre-DCs in the growing 
myometrium. Thus, injection of anti–CSF-1R Abs 12 h before 
sacrifice on E9.5–10.5 increased the proportion of intravascular 
pre-DCs to 23% as compared with the 10% seen in isotype 
control–treated mice (Fig. 10 A). A similar shift was observed in 
overall maintenance of uterine M densities was critically 
dependent on CCR2. Unexpectedly, however, Ccr2/ mice 
showed normal MHCIIlo myometrial M densities at mid-
gestation (Fig. 9 C). This observation could be explained if we 
hypothesized, as in the previous paragraph, that CSF-1 inhib-
ited M maturation in addition to inducing M in situ pro-
liferation. Thus,  we  determined  how  a  single  injection  of 
anti–CSF-1R blocking Abs into pregnant Ccr2/ mice would 
affect the relative densities of MHCIIlo and MHCIIhi Ms in 
the myometrium 48 h later on E9.5–10.5. Indeed, this treat-
ment reduced the density of MHCIIlo Ms but actually in-
creased the density of MHCIIhi Ms, indicating the conversion 
of MHCIIlo to MHCIIhi cells (Fig. 9 C; representative dot 
plots shown in Fig. 9 B, bottom).
Thus, in addition to driving M expansion through the 
dual induction of M in situ proliferation and CCR2 ligand 
expression, CSF-1 activity in the growing myometrium in-
hibited M maturation and thus promoted the relative accu-
mulation of MHCIIlo cells. Interestingly, as compared with 
MHCIIhi Ms from the same samples, MHCIIlo Ms sorted 
from the myometrium at midgestation expressed significantly 
higher mRNA levels of Lyve1, a marker associated with   
Figure 7.  M and DC in situ proliferation in the pregnant and nonpregnant uterus. BrdU incorporation was measured by flow cytometry 2 h 
after injection. Uterine cell suspensions were prepared from uteri of nonpregnant mice (N.P. uterus), from pregnant uteri on E4.5 (E4.5 uterus), and from 
the myometrium (myo) and decidua (dec) on E9.5–10.5 (E9/10). (A and D) Proliferation of uterine Ms (A) and DCs (D) in B6 mice. n = 4–6 mice per group 
from six independent experiments. (B) Quantitative RT-PCR assessment of Csf1 mRNA expression levels in various lymphoid and nonlymphoid organs. 
scLN, subcutaneous LN. n = 2–8 mice per group from at least two independent experiments. (C and E) Proliferation of uterine Ms (C) and DCs (E) after 
CSF-1R blockade. E9.5–10.5 pregnant mice were injected with anti–CSF-1R or isotype control Abs 12 h before sacrifice. n = 3–6 mice per group from five 
independent experiments. (F) Uterine DC proliferation in pregnant Flt3L/ mice. n = 4–5 mice per group from four independent experiments. Error bars 
indicate SEM.1910 CSF-1 links M and DC population dynamics | Tagliani et al.
DC emigration or death (Fig. 10 D). Indeed, 
CSF-1R blockade also had no major effect 
on DC densities in the decidua (Fig. 10 C), 
where CSF-1 activity levels and pre-DC ex-
travasation rates are both low. Together, these 
data suggested that CSF-1–induced pre-DC 
extravasation into the E6.5–9.5 myometrium 
was critical for maintaining DC tissue densi-
ties during this period of massive DC homeo-
static expansion.
DISCUSSION
We have studied M and DC population dynamics in the 
mouse uterus during the first half of gestation, when the 
implanted uterus grows 15-fold in 8 d. Most clearly, our 
results provide a framework for understanding how local 
M tissue densities are specified by in situ levels of CSF-1 
activity (Fig. S2 A). In the E9.5–10.5 myometrium over-
lying each implantation site, we found that high levels of 
CSF-1 activity drive the proliferation of resident Ms as 
well as their expression of the CCR2 ligands CCL2, CCL7, 
and  CCL12. These  chemokines  in  turn  recruit  blood-
borne  Ly6Chi  Mos,  which  differentiate  into  additional 
Ms. Thus,  Ms  within  the  growing  myometrium  un-
dergo a homeostatic expansion through two interlocking 
CSF-1–driven  mechanisms,  and  M  tissue  densities  re-
main  relatively  constant.  In  contrast,  the  decidua  shows 
relatively low levels of CSF-1 activity associated with low 
rates of M proliferation, low levels of CCR2 ligand ex-
pression,  and  the  low  rates  of  Ly6Chi  Mo  extravasation 
typical of most peripheral tissues. Thus, decidual Ms do 
mice  treated  with  anti–CSF-1R Abs  for  a  consecutive  3-d   
period starting on E6.5–7.5 (Fig. 10 A) and was not associated 
with any change in pre-DC abundance in the blood or bone 
marrow  (Fig.  10  B). Together,  these  data  indicated  that   
CSF-1R blockade decreased pre-DC extravasation rates in 
the growing myometrium.
We next determined the effect of CSF-1R blockade on 
DC tissue densities. Strikingly, mice given anti–CSF-1R Abs 
for a consecutive 3 d starting on E6.5–7.5 showed an 45% 
reduction in myometrial CD11bhi DCs densities as com-
pared with isotype control–treated mice (Fig. 10 C) and a 
mild 15% but statistically insignificant reduction in myo-
metrial CD11blo DC densities. For CD11bhi DCs, reduced myo-
metrial tissue densities could only in part be explained by the   
effect of CSF-1R blockade on in situ proliferation rates, as 
this effect was relatively small (a decrease in BrdU labeling 
from 11 to 7%; Fig. 7 E). Moreover, control experiments 
performed on nonpregnant mice showed that uterine DC 
tissue densities were unaffected by 3 d of CSF-1R block-
ade, indicating that the anti–CSF-1R Ab did not induce 
Figure 8.  Ms promote the extravasation of 
circulating Ly6Chi Mos into the growing myo­
metrium through their CSF­1–induced expression 
of CCR2 ligands. (A–C) Mice were injected with anti–
CSF-1R or isotype control Abs 12 h (A and C) or 3 d 
consecutively before sacrifice on E9.5–10.5 (A and B). 
(A) Blood/tissue partitioning of Ly6Chi Mos in the 
myometrium. Representative dot plots from the  
12-h time point are shown on the left; graph data are 
from n = 5–9 mice per group from six independent 
experiments. ev, extravascular; iv, intravascular.  
(B) Blood Ly6Chi Mo abundance. n = 4–5 mice per 
group from three independent experiments.  
(C) Effect of acute CSF-1R blockade on uterine CCR2 
ligand mRNA expression. Ccl2, Ccl7, and Ccl12 mRNA 
levels were measured by quantitative RT-PCR analysis of 
whole tissue. Mice were injected with Abs 12 h before 
sacrifice. n = 4 mice per group compiled over three  
independent experiments. Error bars indicate SEM. dec, 
decidua; myo, myometrium. (D) Analysis of CCL2  
expression in myometrium cell suspensions using  
E9.5–10.5 pregnant MCP1-RFP reporter mice. Data are 
representative of n = 3 MCP1-RFP reporter mice and  
n = 2 pregnant WT mice from one experiment; similar 
results were obtained by tissue immunostaining in an 
independent experiment (n = 3 mice; not depicted).JEM Vol. 208, No. 9 
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matrix sequestration, and receptor-mediated 
ligand scavenging (Pixley and Stanley, 2004). 
How these other levels of regulation influ-
ence in situ CSF-1 activity within the preg-
nant  uterus  is  currently  unclear.  Indeed, 
ligand scavenging by decidual stromal cells 
and trophoblasts, which are some of the few 
adult cell types to express CSF-1R aside 
from  mononuclear  phagocytes,  might  be 
particularly important for maintaining low 
CSF-1 activity levels in the decidua given 
the mild increase in serum CSF-1 levels during pregnancy 
and the abundant epithelial expression of Csf1 mRNA in the 
segments of uterus between implantation sites (Bartocci et al., 
1986; Arceci et al., 1989; Regenstreif and Rossant, 1989).
Although our detailed analysis of M population dynam-
ics was rendered feasible by the unique growth properties of 
the pregnant uterus, the core aspects of our model (Fig. S2 A) 
are consistent with isolated pieces of data from several differ-
ent  systems,  which  suggests  its  potential  broad  relevance.   
For example, CSF-1 is a well-known M mitogen in vitro   
(Pixley and Stanley, 2004), and several studies have implicated 
its up-regulated expression as a cause of increased M prolif-
eration in the context of inflammation (Isbel et al., 2001;   
Le Meur et al., 2002a,b; Jose et al., 2003). Similarly, our failure 
to detect a significant contribution of apoptosis to the loss of 
decidual M density is not only consistent with the relatively 
similar levels of Csf1 mRNA expression in the decidua and 
nonpregnant uterus, but also with older data indicating that 
much lower concentrations of CSF-1 are needed to maintain 
M viability than are needed to induce M proliferation 
(Tushinski et al., 1982). Thus, as inferred from our experiments 
not expand to match the growth of the tissue, and decidual 
M densities decline.
Importantly, our principal evidence for the myometrium 
and decidua containing high and low levels of CSF-1 activity, 
respectively, comes from a functional evaluation of the effect 
of CSF-1R blockade on M in situ proliferation rates. Thus, 
CSF-1R blockade inhibited the high rate of M proliferation 
seen in the myometrium but had no discernable effect on the 
low rate of M proliferation seen in the decidua. We also 
found that the E9.5–10.5 myometrium expressed much 
higher Csf1 mRNA levels than the nonpregnant and E4.5 
uterus and the E9.5–10.5 decidua, as well as all other periph-
eral tissues tested. This observation is consistent with the pres-
ence of scattered CSF-1–expressing cells in the myometrium 
of pregnant CSF-1–lacZ reporter mice (Ryan et al., 2001) 
and suggests that high CSF-1 activity in this tissue layer was 
in part caused by local Csf1 transcriptional induction. How-
ever,  it  is  important  to  note  that  CSF-1  bioavailability  is   
under multiple additional levels of regulation, including the 
generation of different biologically active protein isoforms, 
local production versus acquisition from the blood, extracellular 
Figure 9.  Effect of CSF­1R blockade and CCR2 
deficiency on uterine M densities and differen­
tiation. Uterine cell suspensions were prepared from 
nonpregnant mice in diestrus or from the E9.5–10.5 
myometrium. (A) Effect of CSF-1R blockade on uter-
ine M densities. Mice were injected with anti– 
CSF-1R or isotype control Abs for the consecutive  
3 d before sacrifice. n = 6–8 mice per group from two 
(nonpregnant) or six (pregnant) independent experi-
ments. (B) Representative dot plots of myometrial 
CD45+ cells showing MHCIIhi and MHCIIlo Ms (top 
and bottom boxes, respectively) in the pregnant WT 
mice contributing to the data shown in A (top) or the 
pregnant Ccr2/ mice contributing to the data 
shown in C (bottom). (C) Uterine M densities in 
nonpregnant and pregnant Ccr2/ mice. Some mice 
were also injected i.v. once with anti–CSF-1R Abs 48 h 
before sacrifice. n = 4–8 mice per group from two 
(nonpregnant), six (pregnant), or two (48-h CSF-1R 
blockade) independent experiments. (D) Expression 
profiles of MHCIIlo and MHCIIhi Ms in the E9.5–10.5 
growing myometrium. M subsets were sorted from 
enzymatically dispersed tissues and subjected to qRT-
PCR analysis. n = 3–7 mice from at least four inde-
pendent experiments. Error bars indicate SEM.1912 CSF-1 links M and DC population dynamics | Tagliani et al.
layer (Collins et al., 2009), and our current 
data  find  little  evidence  for  the  selective 
apoptosis of decidual DCs. Rather, the di-
vergence in DC densities between the myo-
metrium and decidua was attributable to a 
low rate of decidual CD11bhi DC in situ 
proliferation and, with relevance to both DC 
subsets, to a major difference in DC precur-
sor recruitment from the blood. In the case of CD11blo DCs, 
these precursors were pre-DCs; in the case of CD11bhi DCs, 
they were pre-DCs and to a very limited extent Ly6Chi Mos. 
Growth of the entire implantation site was also associated 
with a CSF-1–independent and largely Flt3L-independent 
increase in CD11blo DC in situ proliferation rates, suggesting 
that there is a previously unrecognized mitogen for this subset 
that can be produced by peripheral tissues under certain cir-
cumstances. Although clearly insufficient to maintain the tis-
sue density of CD11blo DCs in the decidua, it was likely that 
in situ proliferation contributed to the homeostatic expansion 
of this DC subset in the myometrium. In contrast, CD11bhi 
DCs in the midgestation myometrium showed no change in 
proliferation rates as compared with the E4.5 uterus, suggest-
ing that the growth-induced expansion of this subset relied 
primarily on precursor recruitment.
As with Ly6Chi Mos, we surprisingly found that myo-
metrial pre-DC extravasation rates were reduced upon CSF-1R 
blockade. Because pre-DCs express CSF-1R (Schmid et al., 
2010; unpublished data), it is formally possible that this effect 
reflects an ability of CSF-1 to act as a direct pre-DC chemo-
attractant. However, in separate experiments, we found that 
myometrial  pre-DC  extravasation  was  inhibited  by  PTX, 
which implies that the relevant chemotactic receptor is Gi 
coupled, unlike CSF-1R, and thus likely a chemokine recep-
tor. Thus, it is more likely that CSF-1R induces pre-DC ex-
travasation because it induces expression of a pre-DC–attracting 
chemokine by a cell type already present within the myo-
metrium. Substantiating the existence of this novel pathway will 
require identifying the relevant pre-DC chemoattractant and 
the CSF-1–responding cell type; however, it is striking that it 
on the nonpregnant uterus, apoptosis may only be a feature of 
M population dynamics in the pregnant uterus when mice 
are treated with CSF-1R blocking Abs.
Perhaps most significantly, CSF-1 has recently been shown 
to directly induce CCR2 ligand expression by Ms in vitro 
(Baran et al., 2007; Irvine et al., 2009; El Chartouni et al., 
2010). This result explains the inflammation-associated cor-
relations between CSF-1 expression and local CCL2 levels 
noted in vivo (Guleria and Pollard, 2001; Baran et al., 2007), 
as well as suggestions of CSF-1–mediated Mo recruitment 
(Lenda et al., 2003) without a need to invoke a direct chemo-
tactic role for CSF-1 in leukocyte extravasation. However, 
our demonstration that CSF-1–regulated myometrial Ms 
express physiologically relevant levels of CCR2 ligands in the 
absence  of  inflammation  suggests  that  these  chemokines 
might be more broadly important for regulating peripheral 
tissue Mo/M homeostasis than previously appreciated. Dis-
cerning this role has previously been difficult because the 
abundance of Ly6Chi Mos in the blood of Ccr2/ mice is 
severely reduced at baseline as a result of their impaired exit 
from the bone marrow (Serbina and Pamer, 2006; Tsou et al., 
2007). It will be of particular interest to evaluate whether 
CSF-1 in the tumor microenvironment induces Mo extrava-
sation through effects on CCR2 ligand expression, as this 
would predict that combined use of CSF-1R and CCR2   
antagonists would synergistically reduce tumor-associated 
M abundance.
Our data also provide significant insight into the tissue 
layer–specific  regulation  of  DC  densities  in  the  pregnant 
uterus. Previously, we showed that loss of DC density in the 
decidua was not caused by DC emigration from this tissue 
Figure 10.  CSF­1 influences uterine pre­DC 
extravasation rates and DC densities. (A–C) Mice 
were injected with anti–CSF-1R or isotype control 
Abs 12 h (A) or 3 d consecutively before sacrifice on 
E9.5–10.5 (A–C). (A) Blood/tissue partitioning of  
pre-DCs in the myometrium. Representative dot plots 
from the 12-h time point are shown on the left;  
n = 3–8 mice per group from four and five independent 
experiments, respectively. ev, extravascular; iv, intra-
vascular. (B) Pre-DC abundance in the blood and bone 
marrow. n = 5–8 mice per group from three indepen-
dent experiments. (C) Uterine DC tissue densities.  
n = 6–8 mice per group from six independent experi-
ments. (D) DC tissue densities in the nonpregnant 
uterus after 3 d of CSF-1R blockade. n = 6 mice per 
group from two independent experiments. Error bars 
indicate SEM.JEM Vol. 208, No. 9 
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in tissue homeostasis and host defense. Indeed, we speculate 
that the pathways described here might contribute to the 
maintenance of M and DC densities in different nonuterine 
tissues and tissue layers during tissue growth and in the adult 
organism. Surprisingly, however, M depletion after 3 d of 
CSF-1R blockade had no effect on myometrial wet weights 
(unpublished data), and older work has demonstrated that   
Csf1op/op females carry litters with normal fetal and placental 
weights (Pollard et al., 1991). Additionally, Flt3L/ females, 
which are severely deficient in uterine DCs, show no obvious 
fertility defects (unpublished data). However, this latter result 
needs  to  be  reconciled  with  the  recent  observation  that   
uterine DCs contribute to embryo implantation and early 
decidualization potentially through effects on decidual vascular-
ization (Krey et al., 2008; Plaks et al., 2008). Indeed, Csf1op/op 
females  show  modestly  elevated  embryo  resorption  rates   
(Pollard et al., 1991), and our data here indicate that high 
CSF-1  activity  in  the  growing  myometrium,  through  its   
inhibitory effect on M maturation, induces the accumula-
tion  of  MHCIIlo  Ms  with  a  more  M2-like  phenotype.   
Together, these results suggest that CSF-1–regulated uterine 
Ms and DCs may perform a variety of subtle and potentially 
gestation  stage–dependent  roles  in  myometrial  and  decidual 
growth and function.
MATERIALS AND METHODS
Mice. B6 (CD45.2) mice were purchased from Taconic or Harlan Laborato-
ries. B6.SJL-Ptprca/BoyAiTac (B6 CD45.1), Ccr2/(Kuziel et al., 1997), and 
Flt3L/  (McKenna  et  al.,  2000)  mice  were  purchased  from Taconic.   
CX3CR1GFP/GFP mice (Jung et al., 2000) were a gift of D. Littman (New  York 
University, New York, NY) and were crossed to B6 CD45.1 to generate the 
CX3CR1GFP/+ CD45.1+ mice used as Mo donors. MCP1-RFP mice have 
been described previously (Shi et al., 2011) and bear an RFP expression cas-
sette knocked into the Ccl2 locus. The aforementioned mice were all on a   
B6 background, and B6 mice were used as WT mice in all experiments except 
for the one shown in Fig. 2 (A and B), in which we used B6CBAF1/J mice 
(The Jackson Laboratory), and the one in Fig. 4 (A and B), in which we 
pooled data from B6 and B6CBAF1 mice because these data were indistin-
guishable. Mice were maintained in a specific pathogen–free facility, and all 
experiments were approved by the New  York University School of Medicine 
Institutional Animal Care and Use Committee. All nonpregnant mice were 
virgin females treated with progesterone to induce a diestrus-like state. All 
mating experiments used virgin females and B6 males; noon of day of the 
appearance of a copulation plug was counted as E0.5.
Flow cytometry and determination of tissue densities and BrdU in-
corporation rates. Cell suspensions of nonperfused whole uteri or dis-
sected uterine tissue layers were prepared by enzymatic digestion as previously 
described (Collins et al., 2009). A similar protocol was used to prepare cells 
from other lymphoid and nonlymphoid tissues. Cells were pretreated with 
the FcR-blocking mAb 2.4G2. All analyses were performed using a 10-
color LSRII flow cytometer (BD) and FCS Express software (De Novo Soft-
ware), except for the analysis of MCP1-RFP reporter mice, for which we 
used an LSRFortessa cytometer (BD). After forward versus side scatter gating 
to exclude debris, viable leukocytes were identified using the nucleic acid 
dye 7-AAD (BD) and Pacific orange–conjugated anti-CD45 Abs (clone 30-
F11; Invitrogen).  The cells were then subtyped using fluorochrome- or biotin- 
conjugated Abs specific to mouse MHCII (M5/114.15.2), Ly-6C (AL21, 
HK1.4), F4/80 (BM8, C1:A3-1), CD11c (N418), CD11b (M1/70), Gr-1 
(RB6-8C5), B220 (RA3-6B2), CD3 (17A2), CD19 (1D3), NK1.1 (PK138), 
Ter-119, SIRP- (P84), CD135 (A2F10), CD45.1 (A20), and CD115 
forms such a direct parallel with the CSF-1–mediated induc-
tion of CCR2 ligands by myometrial Ms that drives Ly6Chi 
Mo extravasation (Fig. S2 B). CSF-1–induced pre-DC ex-
travasation, whether as a direct or indirect effect, helps explain 
our finding that 3 d of CSF-1R blockade reduced CD11bhi 
DC densities in the growing myometrium, a finding which 
could only in part be ascribed to the reduction in CD11bhi 
DC proliferation after CSF-1R blockade. Indeed, the select 
effect of CSF-1R blockade on CD11bhi DC densities may be 
more the consequence of our aforementioned inference that 
CD11bhi DC expansion is more dependent on precursor ex-
travasation than CD11blo DC expansion. This inference may 
also explain the recent observation that Csf1op/op mice show a 
relative loss of CD11bhi DCs compared with CD11blo DCs in 
a variety of peripheral tissues (Ginhoux et al., 2009). How-
ever, the fact that the absolute DC tissue density defects in 
Csf1op/op mice are not nearly as severe as their M tissue den-
sity defects demonstrates that pre-DC extravasation is also 
mediated in part by non–CSF-1–dependent pathways.
Together, these data place CSF-1 at the top of a regulatory 
hierarchy that couples M and DC population dynamics in 
peripheral tissues through the linked regulation of Mo and 
pre-DC extravasation rates. By virtue of the differences in the 
levels of CSF-1 activity between uterine tissue layers, this 
regulatory mechanism is exploited in the postimplantation 
mouse uterus to coordinate the homeostatic expansion of 
Ms and DCs in the growing myometrium and their de-
crease in density in the decidua. Previously, we argued that 
the decreased density of decidual DCs, in combination with 
their physical entrapment within the tissue, prevents the initi-
ation of immunogenic T cell responses to the fetus and pla-
centa (Collins et al., 2009). Presumably, the parallel reduction 
in decidual M density in the mouse either has its own physi-
ological significance or is a byproduct of a critical need to re-
duce DC densities at the maternal/fetal interface. Provocatively, 
immunohistochemical analyses of placental bed biopsies from 
third trimester pregnant women have suggested that both 
Ms and DCs are more abundant in the deciduae of patients 
with preeclampsia (Lockwood et al., 2006; Huang et al., 2008; 
Schonkeren et al., 2011), an important obstetrical complica-
tion associated with inadequate trophoblast invasion into the 
uterus and impaired uterine vascular remodeling. In addition, 
multiple studies have demonstrated elevated serum CSF-1 
protein levels in preeclamptic patients (Hayashi et al., 1996, 
2003). Although  these  data  are  controversial  (Keith  et  al., 
2000;  Bürk  et  al.,  2001;  Redline,  2001;  Bersinger  and   
Ødegård, 2005; Kim et al., 2007) and do not imply causal   
relationships, they raise the possibility that the CSF-1–coupled 
regulation of M and DC population dynamics in the de-
cidua may have functional implications for human reproduc-
tive health.
In contrast to the decidua, where there is a potentially 
unique  requirement  for  low  M  and  DC  densities,  the   
CSF-1–coupled maintenance of relatively high M and DC 
densities in the growing myometrium might be considered in-
herently beneficial given the multifaceted roles of these cells 1914 CSF-1 links M and DC population dynamics | Tagliani et al.
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